Paediatric models in motion: requirements for model-based decision support at the bedside
- 19 December 2014
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 79 (1), 85-96
- https://doi.org/10.1111/bcp.12287
Abstract
Optimal paediatric pharmacotherapy is reliant on a detailed understanding of the individual patient including their developmental status and disease state as well as the pharmaceutical agents he/she is receiving for treatment or management of side effects. Our appreciation for size and maturation effects on the pharmacokinetic/pharmacodynamic (PK/PD) phenomenon has improved to the point that we can develop predictive models that permit us to individualize therapy, especially in the situation where we are monitoring drug effects or therapeutic concentrations. The growth of efforts to guide paediatric pharmacotherapy via model-based decision support necessitates a coordinated and systematic approach to ensuring reliable and robust output to caregivers that represents the current standard of care and adheres to governance imposed by the host institution or coalition responsible. Model-based systems which guide caregivers on dosing paediatric patients in a more comprehensive manner are in development at several institutions. Care must be taken that these systems provide robust guidance with the current best practice. These systems must evolve as new information becomes available and ultimately are best constructed from diverse data representing global input on demographics, ethnic / racial diversity, diet and other lifestyle factors. Multidisciplinary involvement at the project team level is key to the ultimate clinical valuation. Likewise, early engagement of clinical champions is also critical for the success of model-based tools. Adherence to regulatory requirements as well as best practices with respect to software development and testing are essential if these tools are to be used as part of the routine standard of care.Keywords
Funding Information
- National Institutes of Health (1RC1LM010367-01)
This publication has 51 references indexed in Scilit:
- Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithmsEuropean Journal of Clinical Pharmacology, 2013
- Validation of an Improved Pediatric Weight Estimation StrategyThe Journal of Pediatric Pharmacology and Therapeutics, 2013
- Population Pharmacokinetic Modelling and Design of a Bayesian Estimator for Therapeutic Drug Monitoring of Tacrolimus in Lung TransplantationClinical Pharmacokinetics, 2012
- Model development for EHR interdisciplinary information exchange of ICU common goalsInternational Journal of Medical Informatics, 2011
- Evaluating Performance of a Decision Support System to Improve Methotrexate Pharmacotherapy in Children and Young Adults With CancerTherapeutic Drug Monitoring, 2011
- Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic painImplementation Science, 2010
- A score to predict early risk of recurrence after ischemic strokeNeurology, 2010
- Practical Therapeutic Drug Management in HIV‐Infected Patients: Use of Population Pharmacokinetic Models Supplemented by Individualized Bayesian Dose OptimizationThe Journal of Clinical Pharmacology, 2008
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of WarfarinClinical Pharmacology & Therapeutics, 2008
- Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapyBMC Medical Informatics and Decision Making, 2008